Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Science

• Publication date

  1992-10-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.1439760PMID 1439760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

  1992cited by this paper
• Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein.

  1992cited by this paper
• Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor.

  1992cited by this paper
• Processing of the amyloid protein precursor to potentially amyloidogenic derivatives.

  1992cited by this paper
• Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments

  1992cited by this paper
• Chloroquine inhibits intracellular segradation but not decretion of Alzheimerβ/A4 amyloid precursor protein.

  1992cited by this paper
• Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

  1991cited by this paper
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

  1990cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Evidence for lysosomal processing of amyloid β-protein precursor in cultured cells

  1989cited by this paper
• The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid.

  1989cited by this paper
• Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

  1989cited by this paper
• Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein.

  1989cited by this paper
• Secretion of intact proteins and peptide fragments by lysosomal pathways of protein degradation.

  1989cited by this paper
• Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein

  1989cited by this paper
• Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate.

  1989cited by this paper
• The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease

  1988cited by this paper
• Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease

  1988cited by this paper
• Validation of clinical diagnostic criteria for Alzheimer's disease

  1988cited by this paper
• Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone.

  1988cited by this paper
• Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.

  1987cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

  1987cited by this paper
• Chromosome 21q21 sublocalisation of gene encoding beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome.

  1987cited by this paper
• Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts. Kinetic evidence that the transfer of proteins to lysosomes is not irreversible.

  1987cited by this paper
• Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease.

  1987cited by this paper
• Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease

  1986cited by this paper
• In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein.

  1986cited by this paper
• In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein

  1986cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

  1984cited by this paper
• ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY.

  1964cited by this paper

• Small molecule ensembles reshape amyloid aggregation landscapes

  2026cites this paper
• A Ru(ii)-arene complex with promising anti-Aβ activity

  2026cites this paper
• The role of probiotics, prebiotics, and postbiotics: cellular and molecular pathways activated on glial cells in Alzheimer’s disease

  2025cites this paper
• Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

  2025cites this paper
• Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers.

  2025cites this paper
• Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome

  2024cites this paper
• On the Therapeutic Use of Monoclonal Antibodies Against Amyloid Plaques in Older Adults with Down Syndrome: A Narrative Review and Perspective

  2024cites this paper
• Behavioural pharmacology predicts disrupted signalling pathways and candidate therapeutics from zebrafish mutants of Alzheimer’s disease risk genes

  2024cites this paper
• Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region

  2024cites this paper
• Structural basis of human γ-secretase inhibition by anticancer clinical compounds

  2024cites this paper
• Therapeutic agents for Alzheimer’s disease: a critical appraisal

  2024cites this paper
• Identification and Analysis of Axolotl Homologs for Proteins Implicated in Human Neurodegenerative Proteinopathies

  2024cites this paper
• Diversity of Aβ aggregates produced in a gut-based Drosophila model of Alzheimer’s disease

  2024cites this paper
• Membrane protein chaperone and sodium chloride modulate the kinetics and morphology of amyloid beta aggregation

  2023cites this paper
• Endocytic pathways of pathogenic protein aggregates in neurodegenerative diseases

  2023cites this paper
• Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids

  2023cites this paper
• Soluble and insoluble protein aggregates, endoplasmic reticulum stress, and vascular dysfunction in Alzheimer’s disease and cardiovascular diseases

  2023cites this paper
• A meta-analysis of the relationship between sleep and β-Amyloid biomarkers in Alzheimer’s disease

  2023cites this paper
• Heme-Aβ in SDS micellar environment: Active site environment and reactivity.

  2023cites this paper
• Redox Imbalance in Neurological Disorders in Adults and Children

  2023cites this paper
• Impact of ZnO on structural and electrochemical properties of silver spinel ferrites for asymmetric supercapacitors

  2023cites this paper
• Photobiomodulation for Alzheimer’s disease: photoelectric coupling effect on attenuating Aβ neurotoxicity

  2023cites this paper
• New Insights into Alzheimer’s Disease: Novel Pathogenesis, Drug Target and Delivery

  2023cites this paper
• The 3-(3-oxoisoindolin-1-yl)pentane-2,4-dione (ISOAC1) as a new molecule able to inhibit Amyloid β aggregation and neurotoxicity.

  2023cites this paper
• A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics

  2022cites this paper
• Recent advances of small molecule JNK3 inhibitors for Alzheimer's disease.

  2022cites this paper
• Ganglioside enriched phospholipid vesicles induce cooperative Aβ oligomerization and membrane disruption

  2022cites this paper
• Dementia Prevention and Aromatherapy in Japan.

  2022cites this paper
• Alzheimer's neuropathology in Down syndrome: From gestation to old age

  2022cites this paper
• Causal associations between neuroinflammation and Alzheimer's disease risk

  2022cites this paper
• Apolipoprotein E4 inhibits γ‐secretase activity via binding to the γ‐secretase complex

  2022cites this paper
• Amyloid Beta Peptide-Mediated Alterations in Mitochondrial Dynamics and its Implications for Alzheimer's Disease.

  2022cites this paper
• Presenilin Deficiency Increases Susceptibility to Oxidative Damage in Fibroblasts

  2022cites this paper
• Simultaneous binding of heme and Cu with amyloid β peptides: active site and reactivities.

  2022cites this paper
• Alzheimer’s disease – the journey of a healthy brain into organ failure

  2022cites this paper
• Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta

  2021cites this paper
• Dipeptidyl peptidase 4 contributes to Alzheimer’s disease–like defects in a mouse model and is increased in sporadic Alzheimer’s disease brains

  2021cites this paper
• Impaired Iron Homeostasis and Haematopoiesis Impacts Inflammation in the Ageing Process in Down Syndrome Dementia

  2021cites this paper
• Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer’s disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma

  2021cites this paper
• Impairment of visual cortical plasticity by amyloid-beta species.

  2021cites this paper
• γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human Glioma Cells via Smad5-downregulated E-cadherin Expression

  2021cites this paper
• Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?

  2021cites this paper
• Ru(II)-Dppz Derivatives and Their Interactions with DNA: Thirty Years and Counting

  2021cites this paper
• Novel strategies for the fight of Alzheimer’s disease targeting amyloid-β protein

  2021cites this paper
• Insights into β-amyloid transition prevention by cucurbit[7]uril from molecular modeling

  2021cites this paper
• Anchoring of Amyloid-β onto Polyunsaturated Phospholipid Membranes

  2021cites this paper
• Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles

  2021cites this paper
• Transient disorder along pathways to amyloid.

  2021cites this paper
• Precision Mapping of Amyloid-β Binding Reveals Perisynaptic Localization and Spatially Restricted Plasticity Deficits

  2021influential citation
• A Three-Dimensional Sensor to Recognize Amyloid-β in Blood Plasma of Patients

  2020cites this paper
• Preferred Endocytosis of Amyloid Precursor Protein from Cholesterol-Enriched Lipid Raft Microdomains

  2020cites this paper
• Genomics of Alzheimer’s disease

  2020cites this paper
• Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease.

  2020cites this paper
• All-trans retinoic acid in Alzheimer's disease

  2020cites this paper
• Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease

  2020cites this paper
• Protective mechanism of kaempferol against Aβ25-35-mediated apoptosis of pheochromocytoma (PC-12) cells through the ER/ERK/MAPK signalling pathway

  2020cites this paper
• Senile Plaques and Neurofibrillary Tangles: The Concurrent Lesions of Alzheimerâ•Žs Disease

  2020cites this paper
• Hibiscus sabdariffa L.: A potent natural neuroprotective agent for the prevention of streptozotocin-induced Alzheimer's disease in mice.

  2020cites this paper
• Gold nanoparticles assisted sensitivity improvement of interdigitated microelectrodes biosensor for amyloid-β detection in plasma sample

  2020cites this paper
• Amyloid-Beta Mediates Homeostatic Synaptic Plasticity

  2020cites this paper
• Does Diet Have a Role in the Treatment of Alzheimer's Disease?

  2020cites this paper
• Damage Mechanisms to Oligodendrocytes and White Matter in Central Nervous System Injury: The Australian Context

  2020cites this paper
• Analyzing microglial-associated Aβ in Alzheimer’s disease transgenic mice with a novel mid-domain Aβ-antibody

  2020cites this paper
• Abrogation of type-I interferon signalling alters the microglial response to Aβ1–42

  2020cites this paper
• Pine Bark Polyphenolic Extract Attenuates Amyloid-β and Tau Misfolding in a Model System of Alzheimer’s Disease Neuropathology

  2020cites this paper
• Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases.

  2020cites this paper
• Unraveling the complexity of γ-secretase.

  2020cites this paper
• Targeting the neurotoxic species in Alzheimer’s disease: inhibitors of A (cid:1) oligomerization

  2020cites this paper
• Nerve Growth Factor Pathobiology During the Progression of Alzheimer’s Disease

  2019cites this paper
• Investigation of neuronal activity in a murine model of Alzheimer’s disease using in vivo two-photon calcium imaging

  2019cites this paper
• Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders

  2019cites this paper
• Effects of in vivo conditions on amyloid aggregation.

  2019cites this paper
• γ-Secretase and its modulators: Twenty years and beyond.

  2019cites this paper
• A cellular complex of BACE1 and γ-secretase sequentially generates Aβ from its full-length precursor

  2019cites this paper
• Infection‐induced endothelial amyloids impair memory

  2019cites this paper
• Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics

  2019cites this paper
• Synaptic Elimination in Neurological Disorders

  2019cites this paper
• PI3K activation prevents Aβ42-induced synapse loss and favors insoluble amyloid deposits formation

  2019cites this paper
• Nitrite reductase activity of heme and copper bound Aβ peptides.

  2019cites this paper
• Carbon nanomaterials and amyloid‐beta interactions: potentials for the detection and treatment of Alzheimer's disease?

  2019cites this paper
• PI3K activation prevents Aβ42-induced synapse loss and favors insoluble amyloid deposit formation

  2019cites this paper
• Role of Withaferin A as a Neuroprotectant against Beta Amyloid Induced Toxicity and associated mechanism

  2019cites this paper
• Full genome analysis of microglial activation : ramifications of TREM2

  2019cites this paper
• Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

  2019cites this paper
• Amyloid beta peptides, locus coeruleus-norepinephrine system and dense core vesicles.

  2019cites this paper
• Molecular mechanisms of human mitochondrial dynamics : inspiration and challenge

  2019cites this paper
• O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production

  2019cites this paper
• Tau deletion reduces plaque‐associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease

  2019cites this paper
• Polyphenols as Potential Therapeutic Drugs in Neurodegeneration

  2019cites this paper
• Impact of social relationships on Alzheimer’s memory impairment: mechanistic studies

  2018cites this paper
• Intracellular tracing of amyloid vaccines through direct fluorescent labelling

  2018cites this paper
• T 2 Signal Changes Indicate Tau Pathophysiology in a Murine Alzheimer ' s Disease Model

  2018cites this paper
• Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action

  2018cites this paper
• Synthesis and characterisation of novel phenanthroline quinone derivatives and their evaluation as Alzheimer's disease therapeutic active ingredients

  2018cites this paper
• 5. Literaturverzeichnis

  2018cites this paper
• Justicidin A Reduces β-Amyloid via Inhibiting Endocytosis of β-Amyloid Precursor Protein

  2018cites this paper
• Amyloid-beta Exacerbates Behavioral Deficits in Mice After Repeated Mild TBI

  2018cites this paper
• A Mechanistic Understanding of Self-Propagating Amyloid-β Oligomer Conformations in Alzheimer Disease

  2018cites this paper
• Inflammation as a central mechanism in Alzheimer's disease

  2018cites this paper
• Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer's Disease Model.

  2018cites this paper